What is Rigel Pharmaceuticals's revenue?

Rigel Pharmaceuticals (RIGL) generated $299.8M in revenue over the trailing twelve months, up 47.6% year over year.

Is Rigel Pharmaceuticals profitable?

Rigel Pharmaceuticals reported $364.2M in net income over the trailing twelve months, a 121.5% net margin.

What are Rigel Pharmaceuticals's profit margins?

Gross margin is 93.4% and operating margin is 41.6%, with a 121.5% net margin.

What is Rigel Pharmaceuticals's earnings per share?

Rigel Pharmaceuticals's diluted EPS over the trailing twelve months is $19.28.

Where does Rigel Pharmaceuticals's income statement data come from?

Every line is extracted from Rigel Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Rigel Pharmaceuticals RIGL Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Total revenue	$58.82M-15.7%	$69.8M+0.5%	$69.46M-31.7%	$101.69M+90.7%	$53.33M-7.4%
Total cost of revenue	$4.61M-22.7%	$5.96M+25.3%	$4.75M+5.5%	$4.5M+2.2%	$4.41M-23.8%
Gross profit	$54.21M-15.1%	$63.85M-1.3%	$64.71M-33.4%	$97.18M+98.6%	$48.92M-5.6%
Gross margin	92.2%+0.7pp	91.5%-1.7pp	93.2%-2.4pp	95.6%+3.8pp	91.7%+1.8pp
Research and development	$11.68M+9.3%	$10.69M+45.3%	$7.35M+7.8%	$6.82M-19.1%	$8.44M+49.8%
Selling, general and administrative	$30.65M+2.2%	$29.99M+3.6%	$28.94M-1.1%	$29.26M+5.6%	$27.72M-6.1%
Total costs & expenses	$46.93M+0.6%	$46.63M+13.6%	$41.04M+1.1%	$40.58M+0.1%	$40.56M-0.9%
Operating income	$11.89M-48.7%	$23.17M-18.5%	$28.42M-53.5%	$61.1M+378%	$12.77M-23.3%
Operating margin	20.2%-13.0pp	33.2%-7.7pp	40.9%-19.2pp	60.1%+36.1pp	23.9%-5.0pp
Interest expense	$1.43M-15.7%	$1.7M-10.3%	$1.89M+1.1%	$1.87M+1.1%	$1.85M-5.2%
Income before income taxes	$11.66M-48.7%	$22.71M-17.8%	$27.62M-54.0%	$59.98M+421%	$11.51M-24.4%
Income tax expense	$3M+101%	-$245.35M-87,525%	-$280K-176%	$369K+468%	$65K-92.6%
Net income	$8.65M-96.8%	$268.07M+861%	$27.9M-53.2%	$59.61M+421%	$11.45M-20.2%
Net margin	14.7%-369pp	384%+344pp	40.2%-18.5pp	58.6%+37.2pp	21.5%-3.4pp
Diluted earnings per share	$0.44-96.9%	$14.10+866%	$1.46-55.5%	$3.28+421%	$0.63-22.2%
EBITDA	$12.48M-47.5%	$23.77M-18.1%	$29.02M-53.0%	$61.71M+361%	$13.38M-22.5%
EBITDA margin	21.2%-12.8pp	34.1%-7.7pp	41.8%-18.9pp	60.7%+35.6pp	25.1%-4.9pp
EBIT	$11.89M-48.7%	$23.17M-18.5%	$28.42M-53.5%	$61.1M+378%	$12.77M-23.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Rigel Pharmaceuticals.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rigel Pharmaceuticals's revenue?: Rigel Pharmaceuticals (RIGL) generated $299.8M in revenue over the trailing twelve months, up 47.6% year over year.
Is Rigel Pharmaceuticals profitable?: Rigel Pharmaceuticals reported $364.2M in net income over the trailing twelve months, a 121.5% net margin.
What are Rigel Pharmaceuticals's profit margins?: Gross margin is 93.4% and operating margin is 41.6%, with a 121.5% net margin.
What is Rigel Pharmaceuticals's earnings per share?: Rigel Pharmaceuticals's diluted EPS over the trailing twelve months is $19.28.
Where does Rigel Pharmaceuticals's income statement data come from?: Every line is extracted from Rigel Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.